Setsuo Funasaka

E7050: A dual c‐Met and VEGFR‐2 tyrosine kinase inhibitor promotes tumor regression and prolongs survival in mouse xenograft models

Takayuki Nakagawa, Osamu Tohyama, Atsumi Yamaguchi et al. · Cancer Science · 2009 · 104 citations · Full text

Medicine, Oncology, Pharmacology +17

Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial

Peng Yuan, Xichun Hu, Tao Sun et al. · European Journal of Cancer · 2019 · 88 citations

Medicine, Oncology, Pharmacology +11

Catalytic and Stereoselective Glycosylation with Glucosyl Thioformimidates

Hiroyuki Chiba, Setsuo Funasaka, Teruaki Mukaiyama · Bulletin of the Chemical Society of Japan · 2003 · 40 citations

Pharmacy, Biochemistry, Chemistry +16

E7090, a Novel Selective Inhibitor of Fibroblast Growth Factor Receptors, Displays Potent Antitumor Activity and Prolongs Survival in Preclinical Models

Saori Watanabe Miyano, Yuji Yamamoto, Kotaro Kodama et al. · Molecular Cancer Therapeutics · 2016 · 37 citations · Full text

Medicine, Oncology, Pharmacology +16

Catalytic and Chemoselective Glycosylation between “Armed” and “Disarmed” Glycosyl <i>p</i>-Trifluoromethylbenzylthio-<i>p</i>-trifluoromethylphenyl Formimidates

Hiroyuki Chiba, Setsuo Funasaka, Koichi Kiyota et al. · Chemistry Letters · 2002 · 24 citations

Natural Sciences, Chemistry, Carbohydrate Chemistry +13